ArticleTransplantation and cellular therapy2024

Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System.

Ryan Storgard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.